21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.32.Z - Other real estate activities on behalf of third parties
70.22.Z - Head office activities and management consultancy
85.60.Z - Educational support activities
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.B - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
87.10.Z - Social assistance with accommodation providing nursing care
87.20.Z - Social assistance with accommodation for people with mental disorders or addictions
87.30.Z - Social assistance with accommodation for elderly people or those with mobility impairments
87.90.Z - Other social assistance with accommodation
88.10.Z - Social assistance without accommodation for elderly people or those with disabilities
88.91.Z - Daycare for children
88.99.Z - Other social assistance without accommodation, not elsewhere classified
96.02.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -2,6 | -2,1 | -2,1 | 0 |
Gross profit (loss) | 3,3 | 2 | -0,4 | -122,4 |
EBITDA | -2,6 | -2,1 | -2,1 | 0 |
Short time liabilities | 1,3 | 1,3 | 0,7 | -46,5 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 13,8 | 15,8 | 15,3 | -2,8 |
Operating profit (EBIT) | -2,6 | -2,1 | -2,1 | 0 |
Assets | 15,1 | 17,1 | 16 | -6,2 |
Net profit (loss) | 3,3 | 2 | -0,4 | -122,4 |
Cash | 15 | 16,9 | 15,8 | -6,3 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,3 | 1,3 | 0,7 | -46,5 |
Working assets | 15 | 17 | 16 | -6,2 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 23,7 | 12,6 | -2,9 | -15,5 |
Equity capital to total assets | 91,2 | 92,3 | 95,6 | 3,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 11.382972717285156 | 12.886072158813477 | 22.607473373413086 | 9,7 |
Net dept to EBITDA | 5.800447940826416 | 8.183614730834961 | 7.670533180236816 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane